286 related articles for article (PubMed ID: 31520695)
1. Outcomes of Resectability Assessment of the Dutch Colorectal Cancer Group Liver Metastases Expert Panel.
Huiskens J; Bolhuis K; Engelbrecht MR; De Jong KP; Kazemier G; Liem MS; Verhoef C; de Wilt JH; Punt CJ; van Gulik TM;
J Am Coll Surg; 2019 Dec; 229(6):523-532.e2. PubMed ID: 31520695
[TBL] [Abstract][Full Text] [Related]
2. Intersurgeon Variability in Local Treatment Planning for Patients with Initially Unresectable Colorectal Cancer Liver Metastases: Analysis of the Liver Expert Panel of the Dutch Colorectal Cancer Group.
Bond MJG; Kuiper BI; Bolhuis K; Komurcu A; van Amerongen MJ; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik T; Hermans JJ; de Jong KP; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; Kazemier G; May AM; Punt CJA; Swijnenburg RJ
Ann Surg Oncol; 2023 Sep; 30(9):5376-5385. PubMed ID: 37118612
[TBL] [Abstract][Full Text] [Related]
3. The role of tumour biological factors in technical anatomical resectability assessment of colorectal liver metastases following induction systemic treatment: An analysis of the Dutch CAIRO5 trial.
Bolhuis K; Bond MJG; Van Amerongen MJ; Komurcu A; Chapelle T; Dejong CHC; Engelbrecht MRW; Gerhards MF; Grünhagen DJ; van Gulik TM; Hermans JJ; De Jong KP; Kazemier G; Klaase JM; Kok NFM; Leclercq WKG; Liem MSL; van Lienden KP; Molenaar IQ; Neumann UP; Patijn GA; Rijken AM; Ruers TM; Verhoef C; de Wilt JHW; May AM; Punt CJA; Swijnenburg RJ;
Eur J Cancer; 2023 Apr; 183():49-59. PubMed ID: 36801606
[TBL] [Abstract][Full Text] [Related]
4. Outcome after laparoscopic radiofrequency ablation of technically resectable colorectal liver metastases.
Hammill CW; Billingsley KG; Cassera MA; Wolf RF; Ujiki MB; Hansen PD
Ann Surg Oncol; 2011 Jul; 18(7):1947-54. PubMed ID: 21399885
[TBL] [Abstract][Full Text] [Related]
5. BRAF V600E potentially determines "Oncological Resectability" for "Technically Resectable" colorectal liver metastases.
Kobayashi S; Takahashi S; Nomura S; Kojima M; Kudo M; Sugimoto M; Konishi M; Gotohda N; Taniguchi H; Yoshino T
Cancer Med; 2021 Oct; 10(20):6998-7011. PubMed ID: 34535965
[TBL] [Abstract][Full Text] [Related]
6. Secondary technical resectability of colorectal cancer liver metastases after chemotherapy with or without selective internal radiotherapy in the randomized SIRFLOX trial.
Garlipp B; Gibbs P; Van Hazel GA; Jeyarajah R; Martin RCG; Bruns CJ; Lang H; Manas DM; Ettorre GM; Pardo F; Donckier V; Benckert C; van Gulik TM; Goéré D; Schoen M; Pratschke J; Bechstein WO; de la Cuesta AM; Adeyemi S; Ricke J; Seidensticker M
Br J Surg; 2019 Dec; 106(13):1837-1846. PubMed ID: 31424576
[TBL] [Abstract][Full Text] [Related]
7. Strategies to convert to resectability the initially unresectable colorectal liver metastases.
Popescu I; Alexandrescu S; Croitoru A; Boros M
Hepatogastroenterology; 2009; 56(91-92):739-44. PubMed ID: 19621694
[TBL] [Abstract][Full Text] [Related]
8. Synchronous colorectal liver metastases: the "surgeon as oncologist" perspective.
Shah K; Clary B
Minerva Chir; 2013 Feb; 68(1):49-76. PubMed ID: 23584266
[TBL] [Abstract][Full Text] [Related]
9. Strategies to Increase the Resectability of Patients with Colorectal Liver Metastases: A Multi-center Case-Match Analysis of ALPPS and Conventional Two-Stage Hepatectomy.
Ratti F; Schadde E; Masetti M; Massani M; Zanello M; Serenari M; Cipriani F; Bonariol L; Bassi N; Aldrighetti L; Jovine E
Ann Surg Oncol; 2015; 22(6):1933-42. PubMed ID: 25564160
[TBL] [Abstract][Full Text] [Related]
10. Surgical Resection Preferences and Perceptions among Medical Oncologists Treating Liver Metastases from Colorectal Cancer.
Choti MA; Thomas M; Wong SL; Eaddy M; Pawlik TM; Hirose K; Weiss MJ; Kish J; Green MR
Ann Surg Oncol; 2016 Feb; 23(2):375-81. PubMed ID: 26561404
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and prognostic relevance of KRAS, BRAF, PI3K and TP53 genetic mutation analysis for resectable and unresectable colorectal liver metastases: A systematic review of the current evidence.
Tsilimigras DI; Ntanasis-Stathopoulos I; Bagante F; Moris D; Cloyd J; Spartalis E; Pawlik TM
Surg Oncol; 2018 Jun; 27(2):280-288. PubMed ID: 29937183
[TBL] [Abstract][Full Text] [Related]
12. Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study.
Isoniemi H; Uutela A; Nordin A; Lantto E; Kellokumpu I; Ovissi A; Kosunen J; Kallio R; Soveri LM; Salminen T; Ålgars A; Lamminmäki A; Halonen P; Ristamäki R; Räsänen J; Karjula H; Vaalavuo Y; Lavonius M; Osterlund P
Br J Surg; 2021 Jul; 108(7):817-825. PubMed ID: 33749772
[TBL] [Abstract][Full Text] [Related]
13. Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study).
Hatano E; Okuno M; Nakamura K; Ishii T; Seo S; Taura K; Yasuchika K; Yazawa T; Zaima M; Kanazawa A; Terajima H; Kaihara S; Adachi Y; Inoue N; Furumoto K; Manaka D; Tokka A; Furuyama H; Doi K; Hirose T; Horimatsu T; Hasegawa S; Matsumoto S; Sakai Y; Uemoto S
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):634-45. PubMed ID: 25926024
[TBL] [Abstract][Full Text] [Related]
14. Treatment strategies in colorectal cancer patients with initially unresectable liver-only metastases, a study protocol of the randomised phase 3 CAIRO5 study of the Dutch Colorectal Cancer Group (DCCG).
Huiskens J; van Gulik TM; van Lienden KP; Engelbrecht MR; Meijer GA; van Grieken NC; Schriek J; Keijser A; Mol L; Molenaar IQ; Verhoef C; de Jong KP; Dejong KH; Kazemier G; Ruers TM; de Wilt JH; van Tinteren H; Punt CJ
BMC Cancer; 2015 May; 15():365. PubMed ID: 25943574
[TBL] [Abstract][Full Text] [Related]
15. Downstaging by regional chemotherapy of non-resectable isolated colorectal liver metastases.
Link KH; Pillasch J; Formentini A; Sunelaitis E; Leder G; Safi F; Kornmann M; Beger HG
Eur J Surg Oncol; 1999 Aug; 25(4):381-8. PubMed ID: 10419708
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy and targeted therapy for patients with initially unresectable colorectal liver metastases, focusing on conversion hepatectomy and long-term survival.
Beppu T; Miyamoto Y; Sakamoto Y; Imai K; Nitta H; Hayashi H; Chikamoto A; Watanabe M; Ishiko T; Baba H
Ann Surg Oncol; 2014 Jun; 21 Suppl 3():S405-13. PubMed ID: 24570379
[TBL] [Abstract][Full Text] [Related]
18. Locoregional surgical and interventional therapies for advanced colorectal cancer liver metastases: expert consensus statements.
Abdalla EK; Bauer TW; Chun YS; D'Angelica M; Kooby DA; Jarnagin WR
HPB (Oxford); 2013 Feb; 15(2):119-30. PubMed ID: 23297723
[TBL] [Abstract][Full Text] [Related]
19. Pan-European survey on current treatment strategies in patients with upfront resectable colorectal liver metastases.
Kuiper BI; Abu Hilal M; Aldrighetti LA; Björnsson B; D'Hondt M; Dopazo C; Fretland ÅA; Isoniemi H; Philip Jonas J; Kazemier G; Lesurtel M; Primrose J; Schnitzbauer AA; Buffart T; Gruenberger B; Swijnenburg RJ; Gruenberger T
HPB (Oxford); 2024 May; 26(5):639-647. PubMed ID: 38373870
[TBL] [Abstract][Full Text] [Related]
20. Perioperative chemotherapy for resectable colorectal liver metastases: where now?
Jones RP; Malik HZ; Fenwick SW; Poston GJ
Eur J Surg Oncol; 2013 Aug; 39(8):807-11. PubMed ID: 23726258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
